Da. Low et al., QUALITY ASSURANCE OF SERIAL TOMOTHERAPY FOR HEAD AND NECK PATIENT TREATMENTS, International journal of radiation oncology, biology, physics, 42(3), 1998, pp. 681-692
Citations number
20
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: A commercial serial tomotherapy intensity-modulated radiation
therapy (IMRT) treatment planning (Peacock, NOMOS Corp., Sewickley, P
A) and delivery system is in clinical use. The dose distributions are
highly conformal, with large dose gradients often surrounding critical
structures, and require accurate localization and dose delivery. Acce
lerator and patient-specific quality assurance (QA) procedures have be
en developed that address the localization, normalization, and deliver
y of the IMRT dose distributions. Methods and Materials: The dose dist
ribution delivered by serial tomotherapy is highly sensitive to the ac
curacy of the longitudinal couch motion. There is also an unknown sens
itivity of the dose distribution on the dynamic mutlileaf collimator a
lignment. QA procedures were implemented that assess these geometric p
arameters. Evaluations of patient positioning accuracy and stability w
ere conducted by exposing portal films before (single exposure) and af
ter (single or double exposure) treatments. The films were acquired wi
th sequential exposures using the largest available fixed multileaf po
rtal (3.36 x 20 cm(2)). Comparison was made against digitally reconstr
ucted radiographs generated using independent software and appropriate
beam geometries. The delivered dose was verified using homogeneous cu
bic phantoms. Radiographic film was used to determine the localization
accuracy of the delivered isodose distributions, and ionization chamb
ers and thermoluminescent dosimetry (TLD) chips were used to verify ab
solute dose at selected points. Ionization chamber measurements were c
onfined to the target dose regions and TLD measurements were obtained
throughout the irradiated volumes. Because many more TLD measurements
were made, a statistical evaluation of the measured-to-calculated dose
ratio was possible. Results: The accelerator QA techniques provided a
dequate monitoring of the geometric patient movement and dynamic multi
leaf collimator alignment and positional stability. The absolute deliv
ered dose as measured with the ionization chamber varied from 0.94 to
0.98. Based on these measurements, the delivered monitor units for bot
h subsequent QA measurements and patient treatments were adjusted by t
he ratio of measured to calculated dose. TLD measurements showed agree
ment, on average, with the ionization chamber measurements. The distri
bution of TLD measurements in the high-dose regions indicated that mea
sured doses agreed within 4.2% standard deviation of the calculated do
ses. In the low dose regions, the measured doses were on average 5% gr
eater than the calculated doses, due to a lack of leakage dose in the
dose calculation algorithm. Conclusions The QA system provided adequat
e determination of the geometric and dosimetric quantities involved in
the use of IMRT for the head and neck. Ionization chamber and TLD mea
surements provided accurate determination of the absolute delivered do
se throughout target volumes and critical structures, and radiographic
film yielded precise dose distribution localization verification. Por
tal film acquisition and subsequent portal film analysis using 3.36 x
20 cm(2) portals proved useful in the evaluation of patient immobiliza
tion quality. Adequate bony landmarks were imaged when carefully selec
ted portals were used. (C) 1998 Elsevier Science Inc.